We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The company plans to market its BD Onclarity HPV assay to high-throughput labs that process a majority of cervical cancer screening specimens in the U.S. Read More